BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33823711)

  • 1. Vascular endothelial growth factor-mediated peritoneal neoangiogenesis in peritoneal dialysis.
    Shi Y; Hu Y; Cui B; Zhuang S; Liu N
    Perit Dial Int; 2022 Jan; 42(1):25-38. PubMed ID: 33823711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
    Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth factors VEGF and TGF-beta1 in peritoneal dialysis.
    Zweers MM; de Waart DR; Smit W; Struijk DG; Krediet RT
    J Lab Clin Med; 1999 Aug; 134(2):124-32. PubMed ID: 10444025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.
    Zweers MM; Struijk DG; Smit W; Krediet RT
    J Lab Clin Med; 2001 Feb; 137(2):125-32. PubMed ID: 11174469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of HDAC6 in clinical peritoneal dialysis patients and its pathogenic role on peritoneal angiogenesis.
    Shi Y; Ni J; Tao M; Ma X; Wang Y; Zang X; Hu Y; Qiu A; Zhuang S; Liu N
    Ren Fail; 2020 Nov; 42(1):890-901. PubMed ID: 32862739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 and vascular endothelial growth factor expressions are involved in ultrafiltration failure.
    Guo J; Xiao J; Gao H; Jin Y; Zhao Z; Jiao W; Liu Z; Zhao Z
    J Surg Res; 2014 May; 188(2):527-536.e2. PubMed ID: 24559584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor (VEGF) levels in peritoneal dialysis effluent.
    Selgas R; del Peso G; Bajo MA; Molina S; Cirugeda A; Sánchez-Tomero JA; Castro MJ; Castro MA; Vara F
    J Nephrol; 2001; 14(4):270-4. PubMed ID: 11506249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose degradation products in peritoneal dialysis solution impair angiogenesis by dysregulating angiogenetic factors in endothelial and vascular smooth muscle cells.
    Aihara S; Nakano T; Torisu K; Kitazono T
    Clin Exp Nephrol; 2022 Dec; 26(12):1160-1169. PubMed ID: 36070106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum level of vascular endothelial growth factor is influenced by erythropoietin treatment in peritoneal dialysis patients. (Grupo de Estudios Peritoneales de Madrid).
    del Peso G; Selgas R; Bajo MA; Fernández de Castro M; Aguilera A; Cirugeda A; Jiménez C
    Adv Perit Dial; 2000; 16():85-9. PubMed ID: 11045267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on mechanisms of ultrafiltration failure.
    Kim YL
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S123-7. PubMed ID: 19270200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor receptor-3 is a novel target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury.
    Terabayashi T; Ito Y; Mizuno M; Suzuki Y; Kinashi H; Sakata F; Tomita T; Iguchi D; Tawada M; Nishio R; Maruyama S; Imai E; Matsuo S; Takei Y
    Lab Invest; 2015 Sep; 95(9):1029-43. PubMed ID: 26121315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoangiogenesis in the peritoneal membrane.
    Krediet RT; Zweers MM; van der Wal AC; Struijk DG
    Perit Dial Int; 2000; 20 Suppl 2():S19-25. PubMed ID: 10911638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. By reducing production of vascular endothelial growth factor octreotide improves the peritoneal vascular alterations induced by hypertonic peritoneal dialysis solution.
    Günal AI; Celiker H; Akpolat N; Ustündag B; Duman S; Akcicek F
    Perit Dial Int; 2002; 22(3):301-6. PubMed ID: 12227386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells.
    Mandl-Weber S; Cohen CD; Haslinger B; Kretzler M; Sitter T
    Kidney Int; 2002 Feb; 61(2):570-8. PubMed ID: 11849398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chronic inflammatory infusion model of peritoneal dialysis in rats.
    Margetts PJ; Kolb M; Yu L; Hoff CM; Gauldie J
    Perit Dial Int; 2001; 21 Suppl 3():S368-72. PubMed ID: 11887858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.
    Park SH; Lee EG; Kim IS; Kim YJ; Cho DK; Kim YL
    Perit Dial Int; 2004; 24(2):115-22. PubMed ID: 15119632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy.
    Catar RA; Bartosova M; Kawka E; Chen L; Marinovic I; Zhang C; Zhao H; Wu D; Zickler D; Stadnik H; Karczewski M; Kamhieh-Milz J; Jörres A; Moll G; Schmitt CP; Witowski J
    Front Immunol; 2022; 13():821681. PubMed ID: 35185912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal vascular endothelial growth factor C level is related to peritoneal dialysis ultrafiltration.
    Yang WS; Tsai TJ; Shih CL; Huang JW; Chuang HF; Chen MH; Fang CC
    Blood Purif; 2009; 28(1):69-74. PubMed ID: 19439926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysate vascular endothelial growth factor is an independent determinant of serum albumin levels and predicts future withdrawal from peritoneal dialysis in uremic patients.
    Hazama T; Fukami K; Yamagishi S; Kusumoto T; Sakai K; Adachi T; Sonoda K; Kasuga S; Ueda S; Okuda S
    Ther Apher Dial; 2014 Oct; 18(5):391-7. PubMed ID: 24251735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.